Thursday, 29 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· October 4, 2026

ASUS Googlebook 14 Now Available for Purchase in the United States

View original at finance.yahoo.com
ASUS Googlebook 14 Now Available for Purchase in the United States ASUS Computer International Designed for Gemini Intelligence, the ASUS Googlebook 14 empowers users to work, create, and collaborate anywhere with an ultraportable design, personalized AI assistance, and access to desktop-class apps Fremont, CA, Oct…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The laptop weighs 2.18 lb and is 0.43 inches thin, with a CNC-machined magnesium-aluminum alloy chassis finished in Dusk Ash and protected by Nano Ceramic Technology.

    60% confidence

  • Every purchase of the Googlebook 14 comes with up to $500 in additional value through a curated bundle of apps and services.

    60% confidence

  • The Googlebook 14 is tested to meet MIL-STD 810H and ASUS Superior Durability standards.

    60% confidence

  • A 70Wh battery provides up to 18 hours of battery life, and an advanced cooling system sustains performance while keeping operation whisper-quiet.

    60% confidence

  • The ASUS Googlebook 14 (CX9406CAA) is now available for purchase in the United States and is the first-ever ASUS laptop designed for Gemini Intelligence.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com